2017 年 43 巻 3 号 p. 121-128
Recently, clinical pharmacists have contributed to medication consultation and inpatient pharmaceutical services in hospitals. However, there are few reports investigating the effects of an ambulatory care pharmacy for cardiovascular disease in Japan. Here we examined whether an ambulatory care pharmacy improves patient care in the clinical pathway for cardiovascular diseases in North Shinshu. We retrospectively investigated the number of patients in possession of drug profile books from June 2009 to March 2014. Among 175 patients, the rate of carrying drug profile books significantly increased from 85.6% to 96.6% (P < 0.01). According to the guidelines for cardiovascular disease in Japan, we checked the prescriptions from April 2015 to March 2016 to review the appropriate use of medications. We consulted 147 patients and successfully reduced the cost of medicines to 731,132 yen per year by discontinuing the medicines that the doctor and pharmacist considered unnecessary at the time. The ambulatory care pharmacy demonstrated an increase in the number of patients having a drug profile book and a decrease in the cost of medicines associated with cardiovascular diseases. The development of an ambulatory care pharmacy might have the potential to improve the quality of pharmaceutical care in cardiovascular disease.